Logo image of CNTY

CENTURY CASINOS INC (CNTY) Stock Fundamental Analysis

USA - NASDAQ:CNTY - US1564921005 - Common Stock

2.74 USD
+0.03 (+1.11%)
Last: 9/22/2025, 9:36:47 PM
2.74 USD
0 (0%)
After Hours: 9/22/2025, 9:36:47 PM
Fundamental Rating

2

Overall CNTY gets a fundamental rating of 2 out of 10. We evaluated CNTY against 134 industry peers in the Hotels, Restaurants & Leisure industry. CNTY may be in some trouble as it scores bad on both profitability and health. CNTY is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CNTY has reported negative net income.
In the past year CNTY had a positive cash flow from operations.
In multiple years CNTY reported negative net income over the last 5 years.
CNTY had a positive operating cash flow in 4 of the past 5 years.
CNTY Yearly Net Income VS EBIT VS OCF VS FCFCNTY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

CNTY's Return On Assets of -8.77% is on the low side compared to the rest of the industry. CNTY is outperformed by 83.58% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.46%, CNTY is doing worse than 61.94% of the companies in the same industry.
CNTY had an Average Return On Invested Capital over the past 3 years of 4.52%. This is significantly below the industry average of 15.67%.
Industry RankSector Rank
ROA -8.77%
ROE N/A
ROIC 3.46%
ROA(3y)-3.87%
ROA(5y)-3.15%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.52%
ROIC(5y)5.13%
CNTY Yearly ROA, ROE, ROICCNTY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

The Operating Margin of CNTY (8.56%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CNTY has grown nicely.
CNTY has a Gross Margin of 44.57%. This is comparable to the rest of the industry: CNTY outperforms 43.28% of its industry peers.
CNTY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.56%
PM (TTM) N/A
GM 44.57%
OM growth 3Y-22.08%
OM growth 5Y1.73%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.38%
GM growth 5Y-1.02%
CNTY Yearly Profit, Operating, Gross MarginsCNTY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CNTY is destroying value.
The number of shares outstanding for CNTY has been increased compared to 1 year ago.
CNTY has more shares outstanding than it did 5 years ago.
CNTY has a worse debt/assets ratio than last year.
CNTY Yearly Shares OutstandingCNTY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CNTY Yearly Total Debt VS Total AssetsCNTY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

CNTY has an Altman-Z score of 0.51. This is a bad value and indicates that CNTY is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CNTY (0.51) is worse than 76.87% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.51
ROIC/WACC0.46
WACC7.55%
CNTY Yearly LT Debt VS Equity VS FCFCNTY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

CNTY has a Current Ratio of 1.42. This is a normal value and indicates that CNTY is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.42, CNTY is doing good in the industry, outperforming 70.15% of the companies in the same industry.
CNTY has a Quick Ratio of 1.37. This is a normal value and indicates that CNTY is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.37, CNTY is in the better half of the industry, outperforming 71.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.37
CNTY Yearly Current Assets VS Current LiabilitesCNTY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 23.48% over the past year.
CNTY shows a decrease in Revenue. In the last year, the revenue decreased by -2.16%.
The Revenue has been growing by 21.42% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)23.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.59%
Revenue 1Y (TTM)-2.16%
Revenue growth 3Y14.02%
Revenue growth 5Y21.42%
Sales Q2Q%2.99%

3.2 Future

The Earnings Per Share is expected to grow by 20.91% on average over the next years. This is a very strong growth
Based on estimates for the next years, CNTY will show a small growth in Revenue. The Revenue will grow by 3.62% on average per year.
EPS Next Y43.22%
EPS Next 2Y29.86%
EPS Next 3Y20.91%
EPS Next 5YN/A
Revenue Next Year2.11%
Revenue Next 2Y4.11%
Revenue Next 3Y3.62%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CNTY Yearly Revenue VS EstimatesCNTY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
CNTY Yearly EPS VS EstimatesCNTY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CNTY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CNTY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNTY Price Earnings VS Forward Price EarningsCNTY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CNTY indicates a somewhat cheap valuation: CNTY is cheaper than 65.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.43
CNTY Per share dataCNTY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

CNTY's earnings are expected to grow with 20.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.86%
EPS Next 3Y20.91%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CNTY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CENTURY CASINOS INC

NASDAQ:CNTY (9/22/2025, 9:36:47 PM)

After market: 2.74 0 (0%)

2.74

+0.03 (+1.11%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners51.47%
Inst Owner Change-2.27%
Ins Owners10.62%
Ins Owner Change0%
Market Cap82.25M
Analysts84
Price Target3.83 (39.78%)
Short Float %0.15%
Short Ratio0.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.05%
Min EPS beat(2)-30.24%
Max EPS beat(2)-9.85%
EPS beat(4)0
Avg EPS beat(4)-19.6%
Min EPS beat(4)-32.99%
Max EPS beat(4)-5.33%
EPS beat(8)1
Avg EPS beat(8)-114.61%
EPS beat(12)1
Avg EPS beat(12)-189.04%
EPS beat(16)3
Avg EPS beat(16)-145.96%
Revenue beat(2)0
Avg Revenue beat(2)-4.62%
Min Revenue beat(2)-8.36%
Max Revenue beat(2)-0.88%
Revenue beat(4)0
Avg Revenue beat(4)-4.03%
Min Revenue beat(4)-8.36%
Max Revenue beat(4)-0.88%
Revenue beat(8)1
Avg Revenue beat(8)-3.08%
Revenue beat(12)2
Avg Revenue beat(12)-2.29%
Revenue beat(16)4
Avg Revenue beat(16)-1.35%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-138.57%
EPS NY rev (1m)0%
EPS NY rev (3m)-23.83%
Revenue NQ rev (1m)-0.38%
Revenue NQ rev (3m)-0.07%
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)0.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF 6.95
P/B N/A
P/tB N/A
EV/EBITDA 10.43
EPS(TTM)-2.02
EYN/A
EPS(NY)-0.87
Fwd EYN/A
FCF(TTM)-0.85
FCFYN/A
OCF(TTM)0.39
OCFY14.39%
SpS19.15
BVpS-1.38
TBVpS-5.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.77%
ROE N/A
ROCE 4.38%
ROIC 3.46%
ROICexc 3.74%
ROICexgc 4.23%
OM 8.56%
PM (TTM) N/A
GM 44.57%
FCFM N/A
ROA(3y)-3.87%
ROA(5y)-3.15%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.52%
ROIC(5y)5.13%
ROICexc(3y)5.13%
ROICexc(5y)5.92%
ROICexgc(3y)5.77%
ROICexgc(5y)6.66%
ROCE(3y)5.73%
ROCE(5y)6.49%
ROICexcg growth 3Y-28.69%
ROICexcg growth 5Y10.01%
ROICexc growth 3Y-28.84%
ROICexc growth 5Y11.19%
OM growth 3Y-22.08%
OM growth 5Y1.73%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.38%
GM growth 5Y-1.02%
F-Score4
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 10.4
Cap/Depr 74.26%
Cap/Sales 6.51%
Interest Coverage 0.52
Cash Conversion 11.89%
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 1.37
Altman-Z 0.51
F-Score4
WACC7.55%
ROIC/WACC0.46
Cap/Depr(3y)111.83%
Cap/Depr(5y)82.65%
Cap/Sales(3y)8.53%
Cap/Sales(5y)6.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.59%
EPS Next Y43.22%
EPS Next 2Y29.86%
EPS Next 3Y20.91%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.16%
Revenue growth 3Y14.02%
Revenue growth 5Y21.42%
Sales Q2Q%2.99%
Revenue Next Year2.11%
Revenue Next 2Y4.11%
Revenue Next 3Y3.62%
Revenue Next 5YN/A
EBIT growth 1Y-0.06%
EBIT growth 3Y-11.16%
EBIT growth 5Y23.53%
EBIT Next Year-0.95%
EBIT Next 3Y43.86%
EBIT Next 5YN/A
FCF growth 1Y-585.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-63.49%
OCF growth 3YN/A
OCF growth 5YN/A